A groundbreaking cancer treatment has shown remarkable results in clinical trials, achieving 90% remission in patients with certain cancers. The therapy:
- Uses modified immune cells
- Targets specific cancer markers
- Has fewer side effects than chemotherapy
- Could be approved within two years
Oncologists call it 'a game-changer' though questions remain about cost and accessibility.
